Spero Therapeutics Inc (SPRO) Annual Income Statement (USD)
SPRO Quarterly Financials (USD)
Frequently Asked Questions About Spero Therapeutics Inc (SPRO) Stock
Spero Therapeutics Inc's (SPRO) last reported annual revenue was USD 96.74 Million.
Spero Therapeutics Inc's (SPRO) annual revenue growth rate based on the revenue reported in the past 5 years is : 89.43%
Spero Therapeutics Inc's(SPRO) is profitable as of its last reported annual financials.
The net profit margin for Spero Therapeutics Inc's(SPRO) from its laster reported year is 23.58%
The return on equity (ROE) for Spero Therapeutics Inc's(SPRO) from its last reported annual financials is : 24.95%
The return on assets (ROA) for Spero Therapeutics Inc's(SPRO) from its last reported annual financials is : 10.90%
The return on invested capital (ROIC) for Spero Therapeutics Inc's(SPRO) from its last reported annual financials is : 18.75%
The Debt to Equity ratio for Spero Therapeutics Inc's(SPRO) from its last reported annual financials is : 0.00%
The dividend yield for Spero Therapeutics Inc's(SPRO) from its laster reported year is 0.00%
Spero Therapeutics Inc's(SPRO) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SPRO !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
